| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |